Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 11 studies | 34% ± 10% | |
epithelial cell | 7 studies | 34% ± 6% | |
epithelial cell of proximal tubule | 6 studies | 27% ± 8% | |
basal cell | 6 studies | 27% ± 10% | |
ionocyte | 5 studies | 39% ± 9% | |
kidney loop of Henle epithelial cell | 5 studies | 27% ± 8% | |
classical monocyte | 4 studies | 29% ± 13% | |
hematopoietic precursor cell | 4 studies | 20% ± 3% | |
goblet cell | 4 studies | 28% ± 4% | |
keratinocyte | 4 studies | 26% ± 12% | |
renal alpha-intercalated cell | 3 studies | 38% ± 4% | |
extravillous trophoblast | 3 studies | 37% ± 8% | |
type II pneumocyte | 3 studies | 26% ± 8% | |
dendritic cell | 3 studies | 40% ± 19% | |
acinar cell | 3 studies | 56% ± 25% | |
intestinal crypt stem cell | 3 studies | 28% ± 1% | |
myofibroblast cell | 3 studies | 17% ± 1% | |
transit amplifying cell | 3 studies | 37% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 8845.16 | 89 / 89 | 99% | 167.48 | 894 / 901 |
esophagus | 98% | 5872.66 | 1422 / 1445 | 97% | 61.51 | 178 / 183 |
stomach | 95% | 2740.21 | 342 / 359 | 98% | 43.76 | 280 / 286 |
pancreas | 100% | 12025.62 | 328 / 328 | 93% | 39.63 | 165 / 178 |
lung | 90% | 2066.47 | 520 / 578 | 98% | 66.43 | 1130 / 1155 |
intestine | 87% | 2290.88 | 845 / 966 | 97% | 49.57 | 513 / 527 |
liver | 82% | 1908.29 | 186 / 226 | 86% | 25.37 | 350 / 406 |
bladder | 86% | 5102.57 | 18 / 21 | 79% | 37.48 | 397 / 504 |
uterus | 68% | 1110.74 | 115 / 170 | 95% | 62.89 | 436 / 459 |
prostate | 60% | 1130.38 | 146 / 245 | 97% | 31.03 | 485 / 502 |
skin | 81% | 7977.33 | 1460 / 1809 | 62% | 17.60 | 293 / 472 |
thymus | 83% | 1551.56 | 543 / 653 | 58% | 14.04 | 353 / 605 |
breast | 64% | 995.73 | 295 / 459 | 65% | 23.53 | 730 / 1118 |
ovary | 37% | 470.77 | 66 / 180 | 87% | 27.79 | 373 / 430 |
muscle | 100% | 10926.72 | 803 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 75.54 | 45 / 45 |
spleen | 78% | 1508.10 | 187 / 241 | 0% | 0 | 0 / 0 |
adipose | 71% | 1224.35 | 853 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 65% | 3946.27 | 602 / 929 | 0% | 0 | 0 / 0 |
heart | 44% | 762.09 | 382 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 39% | 497.78 | 101 / 258 | 5% | 1.36 | 11 / 230 |
lymph node | 0% | 0 | 0 / 0 | 41% | 9.65 | 12 / 29 |
eye | 0% | 0 | 0 / 0 | 26% | 4.10 | 21 / 80 |
blood vessel | 13% | 174.84 | 171 / 1335 | 0% | 0 | 0 / 0 |
brain | 1% | 10.14 | 21 / 2642 | 4% | 0.73 | 28 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0010226 | Biological process | response to lithium ion |
GO_0006020 | Biological process | inositol metabolic process |
GO_0006796 | Biological process | phosphate-containing compound metabolic process |
GO_0006021 | Biological process | inositol biosynthetic process |
GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0052833 | Molecular function | inositol monophosphate 4-phosphatase activity |
GO_0008934 | Molecular function | inositol monophosphate 1-phosphatase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0052832 | Molecular function | inositol monophosphate 3-phosphatase activity |
Gene name | IMPA2 |
Protein name | Inositol monophosphatase 2 IMPA2 protein (Inositol monophosphatase 2) inositol-phosphate phosphatase (EC 3.1.3.25) Inosine monophosphatase 2 Inositol monophosphatase 2 (IMP 2) (IMPase 2) (EC 3.1.3.25) (Inositol-1(or 4)-monophosphatase 2) (Myo-inositol monophosphatase A2) |
Synonyms | IMP.18P |
Description | FUNCTION: Can use myo-inositol monophosphates, scylloinositol 1,4-diphosphate, glucose-1-phosphate, beta-glycerophosphate, and 2'-AMP as substrates. Has been implicated as the pharmacological target for lithium Li(+) action in brain. . |
Accessions | ENST00000269159.8 [O14732-1] ENST00000625802.2 K7ELF8 Q9UPE8 Q9UPE7 ENST00000588927.5 Q9UNV4 Q6PIP6 O14732 ENST00000383376.9 ENST00000590138.1 ENST00000586230.1 Q9UNV6 Q9UPE6 K7EII9 K7EL65 K7EIH6 ENST00000590107.5 Q9UPE5 ENST00000589238.5 Q9UNV5 |